Kindman, MD, FACC
Medical Director of Therapeutic Strategy, Cardiovascular Diseases
Dr. Kindman studied Biochemistry at Brandeis and Harvard Universities prior to attending medical School at the Icahn School of Medicine at Mount Sinai in New York, Internal Medicine residency at New York-Presbyterian Weill Cornell Medical Center, and Cardiology Fellowship at Stanford. After further research training at Stanford, he joined the departments of Medicine and Cell Biology at Duke Medical Center where he studied intracellular calcium trafficking. He was in private practice from 1996-2010, when he joined the University of North Carolina Chapel Hill. In addition to coronary interventions, his clinical practice included echocardiography, nuclear cardiology, heart failure and arrhythmia management. His clinical research included anticoagulant and antithrombotic trials, lipid lowering trials, and device trials.
Since joining Quintiles, he has continued working in the areas of peripheral, coronary and structural heart pharmacotherapies and devices, heart failure, lipids, anticoagulants, and anticoagulant reversal agents. Many of his projects involve regenerative therapies.